The glaucoma treament Timolol is to be trialed as a treatment for the facial redness of rosacea. Timolol is a non-selective beta-adrenergic receptor antagonist, somewhat similar to Brimonidine. Mirvaso is the recently approved treatment for the red face of rosacea that is based on bromonidine. Timolol has been used in the past as a dermatological agent […]
A recent press release from Foamix gives a view into how well Finacea Foam is selling. Based on Q1 2016 sales of the newly approved Finacea Foam, Bayer HealthCare made a royalty payment of $682,000 to Foamix as a fee for licensing their foaming technology. Along with the comment that Finacea Foam sales are continuing […]
Confirmation today that Foamix’s minocycline based FMX103 is still in clinical trials as a rosacea treatment. A press release from the company tells us that the Phase 2 trials have completed. The trial compared 3% minocycline foam, 1.5% minocycline foam and the vehicle foam. Foamix are hopeful that their foam formulation of topical minocycline can […]
A study has been released that headlines a result that even though Soolantra costs more than Finacea, overall it is actually cheaper than Finacea. The study uses a complicated formula to deduce that even though Soolantra sells for more per tube than Finacea, the overall cost versus the benefit you receive shows that Soolantra is […]
